Crescent Biopharma, Inc.

GOLDMAN SACHS GROUP INC CBIO

Report date

6/30/2024

Quarter

2024 Q2

Filed

8/13/2024

Shares

804,342

Value ($000)

227

Weight

0.0%

2014 Q1 - 2024 Q2 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q2	8/13/2024	227	0.0%	804,342	6/30/2024
2024 Q1	5/15/2024	3,344	0.0%	1,114,708	3/31/2024
2023 Q4	5/14/2024	2,170	0.0%	919,355	12/31/2023
2023 Q3	5/15/2024	1,192	0.0%	794,494	9/30/2023
2023 Q2	5/14/2024	1,364	0.0%	783,731	6/30/2023
2023 Q1	5/14/2024	1,136	0.0%	901,891	3/31/2023
2022 Q4	5/14/2024	205	0.0%	67,671	12/31/2022
2021 Q4	2/17/2022	55	0.0%	38,533	12/31/2021
2021 Q3	1/20/2022	58	0.0%	26,375	9/30/2021
2021 Q2	8/13/2021	286	0.0%	123,407	6/30/2021
2021 Q1	5/17/2021	105	0.0%	34,930	3/31/2021
2020 Q4	2/12/2021	190	0.0%	50,508	12/31/2020
2020 Q3	11/13/2020	269	0.0%	87,526	9/30/2020
2020 Q2	8/12/2020	373	0.0%	99,429	6/30/2020
2020 Q1	5/15/2020	219	0.0%	95,956	3/31/2020
2019 Q4	2/14/2020	416	0.0%	78,665	12/31/2019
2014 Q1	5/15/2014	1,754	0.0%	107,406	3/31/2014